Happy New Year!
Previous news
Petrovax and CanSino Biologics Inc. launch an international clinical trial of the AD5-nCOV vaccine against coronavirus in Russia
This site contains information for medical and pharmaceutical professionals.
To view the content, please, confirm that you have the appropriate qualifications.